Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis

Revision as of 02:16, 7 February 2026 by Nhmkerala (talk | contribs) (Created paper page - 2026-02-07T07:46:14.592406)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Authors: Nikhil Chakravarty, Thrisha Senthilnathan, Sophia Paiola, Priya Gyani, Sebastian Castillo Cario, Estrella Urena, Akash Jeysankar, Prakash Jeysankar, Joseph Ignatius Irudayam, Sumathi Natesan Subramanian, Helen Lavretsky, Shantanu Joshi, Gustavo Garcia Jr., Arunachalam Ramaiah, Vaithilingaraja Arumugaswami

Year: 2024

Journal: Not specified in text

DOI: 10.xxxx/xxxxx or null

PMID: PMID or null

Summary

This review paper discusses the abilities of SARS-CoV-2 and other neurotropic RNA viruses, including Zika virus and Nipah virus, to cross the blood–brain barrier into the central nervous system. It highlights the role of magnetic resonance imaging (MRI) in assessing presence and severity of brain structural changes in COVID-19 patients and presents new insight into key mutations in SARS-CoV-2 variants that may impact on neuropilin 1 binding and CNS invasion.

Key Findings

  • SARS-CoV-2 can infect both peripheral cells capable of crossing the blood–brain barrier and brain endothelial cells to traverse the barrier and spread into the brain.
  • Magnetic resonance imaging (MRI) can be used to better understand the long-term effects of COVID-19 on the brain.

Methodology

  • Study Type: Review
  • Sample Size: Not specified in text
  • Geographic Focus: Multiple locations
  • Time Period: Present day

Topics

Neurology, Virology, MRI

Relevance

This paper adds to the understanding of neurological symptoms associated with COVID-19 and the potential impact of SARS-CoV-2 variants on neuropilin 1 binding and central nervous system invasion.

Source

View the entire paper: File:FEB2-595-2854.pdf